SCHEMBL24536776

SCHEMBL24536776

Fc1c(Cl)ncc2c(OCC(F)(F)F)nc(OCC3(CN4CCCC4)CC3)nc12

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 20/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29680468 1.00 KRAS (0.34) KRAS
SCHEMBL24536822 0.83 KRAS (0.36) KRAS
SCHEMBL29679962 0.83 KRAS (0.36) KRAS
SCHEMBL23043428 0.83 KRAS (0.48) KRAS
SCHEMBL25079976 0.77 KRAS (0.52) KRAS
SCHEMBL30759069 0.77 KRAS (0.52) KRAS
SCHEMBL24535666 0.77 KRAS (0.52) KRAS
SCHEMBL30706827 0.77 KRAS (0.43) KRAS
SCHEMBL24536412 0.76 KRAS (0.38) KRAS
SCHEMBL24535883 0.76 KRAS (0.38) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022132200-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2022-06-23 — — WO disclosed
Send feedback